Finnegan, JohnBeth Virnig2023-10-192023-10-192010-01-21https://hdl.handle.net/11299/257648Runtime 1:30 minutesThis resource is provided for informational purposes only and may not reflect current scientific knowledge or medical recommendations.Welcome to Public Health Moment from the University of Minnesota. Ductal carcinoma in situ -- or DCIS -- is defined as an abnormal collection of cells in the milk ducts of the breast. Today, DCIS accounts for about a fourth of all positive breast cancer screenings. But DCIS is not itself considered breast cancer. As a result, it remains unclear how aggressively to treat the condition. That’s according to University of Minnesota health policy professor Beth Virnig. In a report last week for the National Cancer, she and her colleagues called for more research. <Clip: “This is not actually breast cancer. … in a much, less aggressive way.”> Virnig notes that treatments for DCIS can often result in complications and side effects. <clip: “This is an ongoing issue. … for them, and for their particular risk factors.”> For Public Health Moment, I’m John FinneganenAudio